InnoQuester — Drug Quester Pvt. Ltd.
Access pre-evaluated, licensing-ready healthcare innovations — Built for collaboration and commercialization.
InnoQuester connects validated innovations with industry demand through a structured evaluation pipeline, NDA-protected access, and controlled collaboration workspaces.
Built for secure innovation evaluation, licensing, and industry collaboration.
Innovate. Collaborate. Commercialize.
- Only evaluation-approved opportunities
- NDA required before any access
- Zero unsolicited or low-quality submissions
Reduce evaluation noise. Focus only on licensing-ready opportunities.
Why InnoQuester
For Industry
- Access only evaluation-approved opportunities
- Structured technical validation
- NDA-protected access
- Faster licensing decisions
- No exposure to unverified data
For Innovators
- Industry visibility
- Structured expert feedback
- NDA-protected sharing
- No bypass (platform-led engagement)
- No upfront cost
Core Pillars
Objective Expert Validation
- Independent expert review
- Clear Go / Improve / No-Go outcomes
Decision-Ready Due Diligence
- Deep technical & commercial review
- Clear Go / No-Go pathways
Targeted Industry Access
- Evaluation-approved only
- NDA before any industry review
Controlled Collaboration Execution
- Secure document & Q&A workspace
- Tracked progression, full visibility
How It Works
A structured pipeline from submission to secure collaboration.
- 1Submission
Submit structured innovation details and core documents.
- 2Initial Evaluation (7 days)
Independent experts assess technical and strategic potential.
- 3Detailed Evaluation
In-depth technical and commercial diligence determines readiness.
- 4Industry Access (NDA Required)
Approved innovations move to controlled, NDA-gated access.
- 5Collaboration Workspace
Teams collaborate securely with full audit visibility.
Trust & Control
- No uncontrolled data sharing
- No access without NDA
- All engagement is platform-mediated (no bypass)
- Full audit trail for all interactions
Platform Principles
- Not a marketplace — curated innovations only
- Evaluation-first approach
- Controlled collaboration
- Built for trust-driven transactions